EVOFEM BIOSCIENCES, INC. Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments
EVOFEM BIOSCIENCES, INC. (EVFM) reported Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments of $3.56 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments · last filed 2024-03-27
- EVOFEM BIOSCIENCES, INC. adjustments to additional paid in capital, equity component of convertible debt, subsequent adjustments for the quarter ending 2023-09-30 was $3.56M.
- EVOFEM BIOSCIENCES, INC. adjustments to additional paid in capital, equity component of convertible debt, subsequent adjustments for the quarter ending 2023-06-30 was $499.00K.
- EVOFEM BIOSCIENCES, INC. adjustments to additional paid in capital, equity component of convertible debt, subsequent adjustments for fiscal 2022 was $1.34M.
| Period end | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments 3 month | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments 6 month | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments 12 month |
|---|---|---|---|---|
| 2023-09-30 | $3.56M 10-Q · filed 2023-11-14 | $4.06M derived: sum of 2 quarters · filed 2023-11-14 | ||
| 2023-06-30 | $499.00K 10-Q · filed 2023-11-14 | |||
| 2022-12-31 | $1.34M 10-K · filed 2024-03-27 | |||
| 2020-06-05 | $15.80M 10-Q · filed 2021-11-15 |